Greenlight Capital Re (GLRE)
(Delayed Data from NSDQ)
$13.89 USD
-0.07 (-0.50%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $13.88 -0.01 (-0.07%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$13.89 USD
-0.07 (-0.50%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $13.88 -0.01 (-0.07%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
GreenLight Capital's (GLRE) Q4 Loss Widens, Premiums Down
by Zacks Equity Research
GreenLight Capital's (GLRE) Q4 earnings suffer due to severe catastrophe loss.
Earnings Preview: Greenlight Capital Re (GLRE) Q4 Earnings Expected to Decline
by Zacks Equity Research
Greenlight Capital Re (GLRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Greenlight Capital Re (GLRE) Q4 Earnings Expected to Decline
by Zacks Equity Research
Greenlight Capital Re (GLRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Get Rid of Greenlight Capital (GLRE) Now?
by Zacks Equity Research
Greenlight Capital (GLRE) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
New Strong Sell Stocks for July 5th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Why Greenlight Capital (GLRE) Could Be Positioned for a Slump
by Zacks Equity Research
Greenlight Capital (GLRE) is one stock you should avoid as it has seen a significant price decline and is also seeing negative earnings estimate revisions.
Winners and Losers From Insurance Industry Post Q1 Results
by Tanuka De
We shortlist an array of insurance stocks for investors to either enrich their portfolio or offload post Q1 earnings season.
Zacks Industry Outlook Highlights: Greenlight Capital Re, Kingstone, National General Holdings and Kinsale Capital Group
by Zacks Equity Research
Zacks Industry Outlook Highlights: Greenlight Capital Re, Kingstone, National General Holdings and Kinsale Capital Group
Lower Cat Loss, Pricing to Aid Property & Casualty Insurers
by Zacks Equity Research
While insurers are pricing their policies to address perils in the disaster-prone areas, an overall market softening prevails in both commercial and personal lines.
Greenlight Capital Unveils Innovation Unit, Boosts Services
by Zacks Equity Research
Greenlight Capital's (GLRE) new innovation unit, Greenlight Re, is expected to amp up its efficiency and quality of products and services available to its clients.
Greenlight Capital (GLRE) Incurs Wider-Than-Expected Q4 Loss
by Zacks Equity Research
Greenlight Capital's (GLRE) reserve strengthening, investment loss and cat loss from the Californian wildfires in Q4 drag its bottom line.
Greenlight Reinsurance & Units' Rating Retained by A.M. Best
by Zacks Equity Research
Ratings of Greenlight Reinsurance Limited (GLRE) and its subsidiaries are driven by solid risk-adjusted capitalization and experienced management team.
No Interest Rate Hike: Insurance Stocks in Focus
by Zacks Equity Research
Investors remain hopeful about an interest rate hike this year, as signaled by the Fed committee. We zoom in on three insurance stocks, poised to perform well amid headwinds.
The Zacks Analyst Blog Highlights: First American Financial, Hanover Insurance Group, Atlas Financial and Greenlight Capital Re
by Zacks Equity Research
The Zacks Analyst Blog Highlights: First American Financial, Hanover Insurance Group, Atlas Financial and Greenlight Capital Re
Increased Earnings Estimates Seen for Greenlight Reinsurance (GLRE): Can It Move Higher?
by Zacks Equity Research
Greenlight Reinsurance (GLRE) is seeing solid earnings estimate revisions, and the stock is showing decent short-term momentum as well.
Earnings Estimates Moving Higher for Greenlight Capital (GLRE): Time to Buy?
by Shuvra Shankar Dey
Greenlight Capital (GLRE) could be good choice for investors as it is seeing decent short-term momentum and positive earnings estimate revisions.
Greenlight Capital & its Units' Ratings Retained by A.M. Best
by Zacks Equity Research
The credit ratings of Greenlight Capital (GLRE) and its units have been kept unaltered by A.M. Best, following the company's recent announcement regarding the change of CEO.
A Company's First Profit Can Mean Big Profits to Investors
by Kevin Matras
Kevin Matras screens for companies showing their 'first' profit' and explains why they are ones to watch. Highlighted stocks include XLRN, CCO, GLRE, GPOR and ELNK.